Safety and Efficacy of Ledipasvir –Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6‐11
Conclusion: Ledipasvir –sofosbuvir was well tolerated and highly effective in children 6 to<12 years old with chronic HCV.
Source: Hepatology - Category: Internal Medicine Authors: Karen F. Murray,
William F. Balistreri,
Sanjay Bansal,
Suzanne Whitworth,
Helen M. Evans,
Regino P. Gonzalez ‐Peralta,
Jessica Wen,
Benedetta Massetto,
Kathryn Kersey,
Jiang Shao,
Kimberly L. Garrison,
Bandita Parhy,
Diana M. Brainard,
Rone Tags: Original Article Source Type: research
More News: Children | Chronic Pain | Cirrhosis | Gastroenteritis | Gastroenterology | Headache | Hepatitis | Hepatitis C | Internal Medicine | Migraine | Pain | Perinatology & Neonatology | Study | Virology